333 related articles for article (PubMed ID: 28050775)
1. Neuroprotective Efficacy of Mitochondrial Antioxidant MitoQ in Suppressing Peroxynitrite-Mediated Mitochondrial Dysfunction Inflicted by Lead Toxicity in the Rat Brain.
Maiti AK; Saha NC; More SS; Panigrahi AK; Paul G
Neurotox Res; 2017 Apr; 31(3):358-372. PubMed ID: 28050775
[TBL] [Abstract][Full Text] [Related]
2. Mitigating peroxynitrite mediated mitochondrial dysfunction in aged rat brain by mitochondria-targeted antioxidant MitoQ.
Maiti AK; Spoorthi BC; Saha NC; Panigrahi AK
Biogerontology; 2018 Jul; 19(3-4):271-286. PubMed ID: 29774505
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain.
Wani WY; Gudup S; Sunkaria A; Bal A; Singh PP; Kandimalla RJ; Sharma DR; Gill KD
Neuropharmacology; 2011 Dec; 61(8):1193-201. PubMed ID: 21784090
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of mitochondrial-targeted antioxidant MitoQ against iron ion
Gan L; Wang Z; Si J; Zhou R; Sun C; Liu Y; Ye Y; Zhang Y; Liu Z; Zhang H
Toxicol Appl Pharmacol; 2018 Feb; 341():1-7. PubMed ID: 29317239
[TBL] [Abstract][Full Text] [Related]
5. The mitochondria-targeted antioxidant MitoQ extends lifespan and improves healthspan of a transgenic Caenorhabditis elegans model of Alzheimer disease.
Ng LF; Gruber J; Cheah IK; Goo CK; Cheong WF; Shui G; Sit KP; Wenk MR; Halliwell B
Free Radic Biol Med; 2014 Jun; 71():390-401. PubMed ID: 24637264
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted antioxidant MitoQ ameliorates experimental mouse colitis by suppressing NLRP3 inflammasome-mediated inflammatory cytokines.
Dashdorj A; Jyothi KR; Lim S; Jo A; Nguyen MN; Ha J; Yoon KS; Kim HJ; Park JH; Murphy MP; Kim SS
BMC Med; 2013 Aug; 11():178. PubMed ID: 23915129
[TBL] [Abstract][Full Text] [Related]
7. Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?
Lu C; Zhang D; Whiteman M; Armstrong JS
Antioxid Redox Signal; 2008 Mar; 10(3):651-60. PubMed ID: 17999633
[TBL] [Abstract][Full Text] [Related]
8. The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis.
Lowes DA; Thottakam BM; Webster NR; Murphy MP; Galley HF
Free Radic Biol Med; 2008 Dec; 45(11):1559-65. PubMed ID: 18845241
[TBL] [Abstract][Full Text] [Related]
9. The mitochondria-targeted anti-oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance.
Kang L; Liu S; Li J; Tian Y; Xue Y; Liu X
Cell Prolif; 2020 Mar; 53(3):e12779. PubMed ID: 32020711
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice.
Gioscia-Ryan RA; LaRocca TJ; Sindler AL; Zigler MC; Murphy MP; Seals DR
J Physiol; 2014 Jun; 592(12):2549-61. PubMed ID: 24665093
[TBL] [Abstract][Full Text] [Related]
11. Peroxynitrite induced mitochondrial biogenesis following MnSOD knockdown in normal rat kidney (NRK) cells.
Marine A; Krager KJ; Aykin-Burns N; Macmillan-Crow LA
Redox Biol; 2014; 2():348-57. PubMed ID: 24563852
[TBL] [Abstract][Full Text] [Related]
12. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice.
Mercer JR; Yu E; Figg N; Cheng KK; Prime TA; Griffin JL; Masoodi M; Vidal-Puig A; Murphy MP; Bennett MR
Free Radic Biol Med; 2012 Mar; 52(5):841-9. PubMed ID: 22210379
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties.
Kelso GF; Porteous CM; Coulter CV; Hughes G; Porteous WK; Ledgerwood EC; Smith RA; Murphy MP
J Biol Chem; 2001 Feb; 276(7):4588-96. PubMed ID: 11092892
[TBL] [Abstract][Full Text] [Related]
14. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease.
McManus MJ; Murphy MP; Franklin JL
J Neurosci; 2011 Nov; 31(44):15703-15. PubMed ID: 22049413
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.
Wiegman CH; Michaeloudes C; Haji G; Narang P; Clarke CJ; Russell KE; Bao W; Pavlidis S; Barnes PJ; Kanerva J; Bittner A; Rao N; Murphy MP; Kirkham PA; Chung KF; Adcock IM;
J Allergy Clin Immunol; 2015 Sep; 136(3):769-80. PubMed ID: 25828268
[TBL] [Abstract][Full Text] [Related]
16. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
17. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
Mao P; Manczak M; Shirendeb UP; Reddy PH
Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis.
Chacko BK; Srivastava A; Johnson MS; Benavides GA; Chang MJ; Ye Y; Jhala N; Murphy MP; Kalyanaraman B; Darley-Usmar VM
Hepatology; 2011 Jul; 54(1):153-63. PubMed ID: 21520201
[TBL] [Abstract][Full Text] [Related]
19. MitoQ modulates oxidative stress and decreases inflammation following hemorrhage.
Powell RD; Swet JH; Kennedy KL; Huynh TT; Murphy MP; Mckillop IH; Evans SL
J Trauma Acute Care Surg; 2015 Mar; 78(3):573-9. PubMed ID: 25710429
[TBL] [Abstract][Full Text] [Related]
20. The mitochondria-targeted anti-oxidant MitoQ reduces aspects of mitochondrial fission in the 6-OHDA cell model of Parkinson's disease.
Solesio ME; Prime TA; Logan A; Murphy MP; Del Mar Arroyo-Jimenez M; Jordán J; Galindo MF
Biochim Biophys Acta; 2013 Jan; 1832(1):174-82. PubMed ID: 22846607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
